trial

COMpassion for Psychiatric Disorders And Self-Stigma

NCTId NCT05698589

as of 2026-07-01

Add to landscape Monitor this Ask about this

at a glance

— · Recruiting

Enrollment 336 (estimated)

Sponsored by University Hospital, Strasbourg, France

Primary completion 2028-03-01

Synthesized from structured facts only — each point cited above.

Design & status

Phase

—

Status

Recruiting

Enrollment

336 (estimated)

Study type

Interventional

Allocation

Randomized

Model

Parallel

Masking

Single

Start

2023-04-03

Primary completion

2028-03-01

Eligibility

ALL · 18 Years

Interventions & indications

Drugs

Compassion Focused Therapy Ending Self Stigma

Indications

Bipolar Disorder Autism Spectrum Disorder Borderline Personality Disorder Depression Autism Spectrum Disorder Borderline Personality Disorder Bipolar Disorder Schizophrenia Schizophrenia Depression

Sites

7 total

Bordeaux, FranceBron, FranceClermont-Ferrand, FranceLaxou, FranceMontpellier, FranceReims, FranceStrasbourg, France

Facts & assertions

4 sourced

Enrollment

336

Phase

Primary Completion Date

2028-03-01

Status

RECRUITING

relationships

The graph out of here

drug

Compassion Focused Therapy

drug

Ending Self Stigma

drug

lead_sponsor

University Hospital, Strasbourg, France

company

indication

Bipolar Disorder

indication

Autism Spectrum Disorder

indication

Borderline Personality Disorder

indication